Viking Global Investors LP Insulet Corp Transaction History

Viking Global Investors LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$212.22 - $313.46 $72.8 Million - $108 Million	-342,986 Reduced 56.13%	268,052 $78.9 Million
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $24.2 Million - $30.3 Million	107,637 Added 21.38%	611,038 $140 Million
Q2 2022 Aug 15, 2022	SELL	$186.4 - $279.02 $8.2 Million - $12.3 Million	-43,986 Reduced 8.04%	503,401 $110 Million
Q1 2022 May 16, 2022	SELL	$194.8 - $275.7 $25.5 Million - $36.1 Million	-130,807 Reduced 19.29%	547,387 $146 Million
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $85.5 Million - $107 Million	-334,947 Reduced 33.06%	678,194 $180 Million

Q3 2021 Nov 15, 2021	SELL	$260.36 - $307.27 $152 Million - $179 Million	-582,147 Reduced 36.49%	1,013,141 $288 Million
Q2 2021 Aug 16, 2021	BUY	$225.52 - $304.06 $126 Million - $170 Million	559,324 Added 53.99%	1,595,288 $438 Million
Q1 2021 May 17, 2021	BUY	$235.95 - $293.05 $130 Million - $162 Million	552,435 Added 114.25%	1,035,964 $270 Million
Q4 2020 Feb 16, 2021	BUY	$215.97 - $265.89 $58.1 Million - $71.6 Million	269,197 Added 125.6%	483,529 $124 Million
Q3 2020 Nov 16, 2020	BUY	$192.55 - $236.59 $41.3 Million - $50.7 Million	214,332 New	214,332 $50.7 Million

613

62.9M

339K

916K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $13.7B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.